Kurstriggere i Genmab i sep. 2019
-
9-12/9 IASLC 2019 WCLC: AXL ADC præsenteres oralt.
12-15/9 17th International Myeloma Workshop: 13 abstracts fra Janssen/Genmab bl.a. 4 orale præsentationer (Griffin og PLEIADES) - plus andet godt !
13/9 ECTRIMS: Ofatumumab fase III data i MS præsenteres (abstracts formentlig den 11/9). Ocrevus vil nå omsætning på 3,75 milliarder dollars i år.
26/9 PDUFA dato for DVTd i MM (CASSIOPEIA)
Med tak til Sukkeralf.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind